Avalo Therapeutics Europe (SRL)

Active

VAT

BE 0716.860.484

Address

Place des Barricades 13

1000 Bruxelles

Established

26-12-2018

Principal activity

Manufacture of medicaments

Try for free

Crisis resilience of Avalo Therapeutics Europe

Which companies are best armed against current economic trends and the energy crisis?

2022		2021		2020		2019
Profit/Loss	-€8,550	8%	-€9,272	-35%	-€6,845	0%	-€6,853
Equity	€22,030	598%	-€4,420	-191%	€4,852	-59%	€11,697
Gross margin	-€8,440	8%	-€9,185	-36%	-€6,761	1%	-€6,839

Publications in the Belgian Official Journal for Avalo Therapeutics Europe

Type	Date	Pdf	Subject
	17-11-2022		Resignations - Appointments (NL)
	04-08-2022		Modification Legal Form - Designation - Resignations - Appointments (NL)
	22-09-2021		Resignations - Appointments (NL)
	24-02-2021		Resignations - Appointments (NL)
	28-12-2018		Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Sources

Frequently asked questions

What is the VAT number of Avalo Therapeutics Europe?

The VAT number of Avalo Therapeutics Europe is BE0716860484.

When was Avalo Therapeutics Europe founded?

Avalo Therapeutics Europe was founded on 26-12-2018.

What is the address of Avalo Therapeutics Europe?

The current registered office of Avalo Therapeutics Europe is located at Place des Barricades 13, 1000 Bruxelles.

When was the last time Avalo Therapeutics Europe filed their annual financial statements?

The most recent financial statements of Avalo Therapeutics Europe were filed on 06-07-2023. You can view them here.

How many employees does Avalo Therapeutics Europe have?

There are currently no employees working at Avalo Therapeutics Europe or no workforce information is available.

What is the annual turnover of Avalo Therapeutics Europe?

At the time of its most recent financial statements, Avalo Therapeutics Europe did not publish any turnover figures. Avalo Therapeutics Europe reported a gross margin of -€8,440.00.